Latest Insider Transactions at Personalis, Inc. (PSNL)
This section provides a real-time view of insider transactions for Personalis, Inc. (PSNL). The data is sourced from Form 4 filings with the SEC, which are filed by insiders of Personalis, Inc. to disclose their transactions in the company's securities. By reviewing this information, investors can gain insights into the trading activity of Personalis, Inc.'s insiders and make more informed investment decisions.
Insider Transaction List
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Aug 15
2022
|
John Stephen West President and CEO |
BUY
Grant, award, or other acquisition
|
Direct |
230,000
+27.3%
|
-
|
|
Aug 02
2022
|
Lonnie Shoff |
BUY
Grant, award, or other acquisition
|
Direct |
30,940
+50.0%
|
-
|
|
Jul 28
2022
|
Aaron Tachibana CFO AND COO |
SELL
Open market or private sale
|
Direct |
632
-0.27%
|
$1,896
$3.91 P/Share
|
|
Jul 28
2022
|
Richard Chen CHIEF MEDICAL OFFICER AND EVP |
SELL
Open market or private sale
|
Direct |
632
-0.43%
|
$1,896
$3.91 P/Share
|
|
Jun 17
2022
|
Aaron Tachibana CFO AND COO |
SELL
Open market or private sale
|
Direct |
3,440
-1.46%
|
$10,320
$3.29 P/Share
|
|
Jun 17
2022
|
Richard Chen CHIEF MEDICAL OFFICER AND EVP |
SELL
Open market or private sale
|
Direct |
1,565
-1.06%
|
$4,695
$3.29 P/Share
|
|
Jun 15
2022
|
Aaron Tachibana CFO AND COO |
SELL
Open market or private sale
|
Direct |
6,818
-2.82%
|
$20,454
$3.24 P/Share
|
|
Jun 15
2022
|
Richard Chen CHIEF MEDICAL OFFICER AND EVP |
SELL
Open market or private sale
|
Direct |
6,818
-4.4%
|
$20,454
$3.24 P/Share
|
|
Jun 15
2022
|
Stephen Michael Moore SVP and Chief Legal Officer |
SELL
Open market or private sale
|
Direct |
1,832
-2.42%
|
$5,496
$3.24 P/Share
|
|
Jun 02
2022
|
Richard Chen CHIEF MEDICAL OFFICER AND EVP |
SELL
Open market or private sale
|
Direct |
421
-0.27%
|
$1,263
$3.59 P/Share
|
|
Jun 02
2022
|
Aaron Tachibana CFO AND COO |
SELL
Open market or private sale
|
Direct |
4,187
-1.7%
|
$12,561
$3.59 P/Share
|
|
May 17
2022
|
Ken Ludlum Director |
BUY
Grant, award, or other acquisition
|
Direct |
10,770
+19.84%
|
-
|
|
May 17
2022
|
Alan Colowick Director |
BUY
Grant, award, or other acquisition
|
Direct |
10,770
+44.36%
|
-
|
|
May 17
2022
|
A Blaine Bowman |
BUY
Grant, award, or other acquisition
|
Direct |
10,770
+44.36%
|
-
|
|
May 17
2022
|
Karin Eastham |
BUY
Grant, award, or other acquisition
|
Direct |
10,770
+44.36%
|
-
|
|
May 17
2022
|
Woodrow A Myers Jr |
BUY
Grant, award, or other acquisition
|
Direct |
10,770
+40.06%
|
-
|
|
May 17
2022
|
Olivia Kyusuk Bloom |
BUY
Grant, award, or other acquisition
|
Direct |
10,770
+33.88%
|
-
|
|
May 16
2022
|
Richard Chen CHIEF MEDICAL OFFICER AND EVP |
SELL
Open market or private sale
|
Direct |
1,286
-0.82%
|
$5,144
$4.86 P/Share
|
|
May 16
2022
|
Stephen Michael Moore SVP and Chief Legal Officer |
SELL
Open market or private sale
|
Direct |
664
-0.87%
|
$2,656
$4.86 P/Share
|
|
May 16
2022
|
John Stephen West President and CEO |
SELL
Open market or private sale
|
Direct |
2,408
-0.63%
|
$9,632
$4.86 P/Share
|
|
May 16
2022
|
Aaron Tachibana CFO AND COO |
SELL
Open market or private sale
|
Direct |
1,286
-0.52%
|
$5,144
$4.86 P/Share
|
|
May 02
2022
|
Stephen Michael Moore SVP and Chief Legal Officer |
SELL
Open market or private sale
|
Direct |
5,733
-6.98%
|
$28,665
$5.53 P/Share
|
|
Apr 29
2022
|
Richard Chen CHIEF MEDICAL OFFICER AND EVP |
BUY
Grant, award, or other acquisition
|
Direct |
1,558
+0.98%
|
$6,232
$4.76 P/Share
|
|
Apr 20
2022
|
John Stephen West President and CEO |
BUY
Exercise of conversion of derivative security
|
Direct |
45,061
+10.48%
|
$45,061
$1.84 P/Share
|
|
Apr 13
2022
|
John Stephen West President and CEO |
SELL
Open market or private sale
|
Direct |
64,430
-15.94%
|
-
|
|
Apr 13
2022
|
John Stephen West President and CEO |
BUY
Exercise of conversion of derivative security
|
Direct |
64,430
+13.75%
|
$64,430
$1.84 P/Share
|
|
Mar 17
2022
|
Richard Chen CHIEF MEDICAL OFFICER AND EVP |
SELL
Sale (or disposition) back to the issuer
|
Direct |
1,776
-1.13%
|
$12,432
$7.98 P/Share
|
|
Mar 17
2022
|
Aaron Tachibana CFO AND COO |
SELL
Sale (or disposition) back to the issuer
|
Direct |
3,767
-1.5%
|
$26,369
$7.98 P/Share
|
|
Mar 17
2022
|
John Stephen West President and CEO |
BUY
Grant, award, or other acquisition
|
Direct |
54,347
+13.79%
|
$54,347
$1.84 P/Share
|
|
Mar 15
2022
|
John Stephen West President and CEO |
SELL
Sale (or disposition) back to the issuer
|
Direct |
68,162
-19.28%
|
$477,134
$7.47 P/Share
|
|
Mar 15
2022
|
John Stephen West President and CEO |
BUY
Grant, award, or other acquisition
|
Direct |
68,162
+16.16%
|
$68,162
$1.84 P/Share
|
|
Mar 14
2022
|
John Stephen West President and CEO |
SELL
Sale (or disposition) back to the issuer
|
Direct |
21,206
-6.92%
|
$169,648
$8.15 P/Share
|
|
Mar 14
2022
|
John Stephen West President and CEO |
BUY
Grant, award, or other acquisition
|
Direct |
21,206
+6.47%
|
$21,206
$1.84 P/Share
|
|
Mar 11
2022
|
John Stephen West President and CEO |
SELL
Sale (or disposition) back to the issuer
|
Direct |
10,888
-4.31%
|
$87,104
$8.99 P/Share
|
|
Mar 10
2022
|
John Stephen West President and CEO |
SELL
Sale (or disposition) back to the issuer
|
Direct |
32,897
-11.52%
|
$296,073
$9.38 P/Share
|
|
Mar 03
2022
|
Lightspeed Venture Partners Select Iv, L.P. |
BUY
Open market or private purchase
|
Direct |
4,750
+50.0%
|
$47,500
$10.38 P/Share
|
|
Mar 03
2022
|
Lightspeed Venture Partners Select Iv, L.P. |
BUY
Open market or private purchase
|
Indirect |
261,011
+11.13%
|
$2,349,099
$9.83 P/Share
|
|
Mar 02
2022
|
Aaron Tachibana CFO AND COO |
SELL
Open market or private sale
|
Direct |
4,511
-1.76%
|
$45,110
$10.18 P/Share
|
|
Mar 02
2022
|
Richard Chen CHIEF MEDICAL OFFICER AND EVP |
SELL
Open market or private sale
|
Direct |
471
-0.3%
|
$4,710
$10.18 P/Share
|
|
Mar 02
2022
|
Lightspeed Venture Partners Select Iv, L.P. |
BUY
Open market or private purchase
|
Indirect |
48,989
+2.62%
|
$440,901
$9.96 P/Share
|
|
Mar 01
2022
|
Olivia Kyusuk Bloom |
BUY
Grant, award, or other acquisition
|
Direct |
10,245
+50.0%
|
-
|
|
Jan 28
2022
|
Aaron Tachibana CFO AND COO |
SELL
Open market or private sale
|
Direct |
705
-0.27%
|
$6,345
$9.93 P/Share
|
|
Jan 28
2022
|
Richard Chen CHIEF MEDICAL OFFICER AND EVP |
SELL
Open market or private sale
|
Direct |
705
-0.44%
|
$6,345
$9.93 P/Share
|
|
Jan 19
2022
|
John Stephen West President and CEO |
SELL
Open market or private sale
|
Direct |
64,503
-18.43%
|
$709,533
$11.01 P/Share
|
|
Jan 18
2022
|
John Stephen West President and CEO |
SELL
Open market or private sale
|
Direct |
35,484
-9.21%
|
$390,324
$11.73 P/Share
|
|
Dec 17
2021
|
John Stephen West President and CEO |
SELL
Open market or private sale
|
Direct |
2,732
-0.7%
|
$32,784
$12.8 P/Share
|
|
Dec 17
2021
|
Richard Chen CHIEF MEDICAL OFFICER AND EVP |
SELL
Open market or private sale
|
Direct |
1,563
-0.98%
|
$18,756
$12.8 P/Share
|
|
Dec 17
2021
|
Aaron Tachibana CFO AND COO |
SELL
Open market or private sale
|
Direct |
3,437
-1.32%
|
$41,244
$12.8 P/Share
|
|
Dec 16
2021
|
John Stephen West President and CEO |
SELL
Open market or private sale
|
Direct |
97,268
-20.04%
|
$1,264,484
$13.42 P/Share
|
|
Dec 14
2021
|
Richard Chen CHIEF MEDICAL OFFICER AND EVP |
BUY
Grant, award, or other acquisition
|
Direct |
80,000
+33.32%
|
-
|